Max Healthcare Institute Limited
All news and filings related to Max Healthcare Institute Limited.
View all news & filings- Low impact
Max Healthcare to Shift Registered Office from Maharashtra to Haryana
Max Healthcare Institute Limited is shifting its registered office from Maharashtra to Haryana, following a special resolution passed on July 30, 2026. Newspaper advertisements were published on September 7, 2026, notifying the public of the proposed change and the process for objections.
Read the summary - Medium impact
Max Healthcare Increases Stake in Kalinga Hospital to 66.15% via ₹87.87 Crore Infusion
Max Healthcare infused ₹87.87 Crore into subsidiary Kalinga Hospital Ltd. via rights issue. The company was allotted 50,21,212 equity shares, increasing its stake from 58.28% to 66.15%. Kalinga Hospital remains a subsidiary.
Read the summary - Medium impact
Max Healthcare Infuses ₹87.87 Crore in Subsidiary Kalinga Hospital Ltd.
Max Healthcare Institute Limited's RESIC approved an infusion of ₹87.87 Crore into its subsidiary, Kalinga Hospital Ltd., via rights issue of equity shares. This investment aims to support KHL's capital expenditure, modernization, and operational enhancements. The transaction is expected to complete within 15 days.
Read the summary - High impact
Max Healthcare Inaugurates 400-Bed Tower at Saket Hospital, Expanding Capacity to 1,200 Beds
Max Healthcare inaugurated a new 400-bed tower at its Saket hospital on September 03, 2026, expanding its total capacity to 1,200 beds. This makes it Delhi's largest private hospital. The new facility features advanced technology like surgical robots. The expansion aims to enhance specialized healthcare delivery.
Read the summary - Medium impact
Max Healthcare Subsidiary Receives ₹165 Crore GST Demand Notice
Max Healthcare's subsidiary, Alps Hospital Limited, received a GST show cause cum demand notice for ₹55.23 crore plus interest. Penalties of ₹55.23 crore each under two sections of the CGST Act are also alleged, totaling approximately ₹165 crore. Management is preparing submissions in response.
Read the summary - High impact
Max Healthcare Q1 FY27 Earnings Call Transcript Released
Max Healthcare Institute Limited released its Q1 FY27 earnings call transcript. The company reported 16% year-on-year revenue growth to INR 2,982 crore and 15% EBITDA growth to INR 704 crore. Key expansion projects include a new 202-bed tower at Max Vaishali with INR 425 crore capex. The company is also venturing into the medical education business.
Read the summary - Low impact
Max Healthcare Subsidiary Hearing Adjourned to September 8, 2026
The NCLT Cuttack Bench adjourned the hearing on a petition concerning Max Healthcare's subsidiary, Kalinga Hospital Ltd. The next hearing is scheduled for September 8, 2026. This update follows an earlier intimation on August 7, 2026.
Read the summary - Low impact
Max Healthcare to Participate in Motilal Oswal Investor Conference
Max Healthcare Institute Limited representatives will attend the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026, in Mumbai. An investor presentation will be shared during the event. The company confirmed its participation on August 17, 2026.
Read the summary - Low impact
Max Healthcare Publishes Q1 FY27 Financial Results in Newspapers
Max Healthcare Institute Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved on August 13, 2026, and published on August 14, 2026. The details are available on the company's website and stock exchange portals.
Read the summary - Low impact
Max Healthcare: Audio Recording of Q1 FY27 Earnings Call Available Online
Max Healthcare Institute Limited has released the audio recording of its earnings call for the quarter ended June 30, 2026. The call took place on August 14, 2026, and the recording is available on the company's website.
Read the summary - Medium impact
Max Healthcare ESG Rating Upgraded by CRISIL to 'Strong' Category
Max Healthcare's ESG ratings have been upgraded by CRISIL. The ESG rating improved to CRISIL ESG 68 ('Strong' category) and the Core ESG rating to CRISIL Core ESG 76. CRISIL assigned these ratings independently based on public disclosures.
Read the summary - High impact
Max Healthcare Approves Q1 FY27 Results, Appoints New Executives, and Plans ₹425 Crore Expansion
Max Healthcare approved Q1 FY27 results. The company approved a ₹425 Crore capex for expanding Max Super Speciality Hospital, Vaishali, adding ~250 beds by Nov 2029. Mr. Ajay Vij was appointed Director - Chief Supply Chain & Procurement Officer, and Mr. Pawan Kumar Marella as Senior Director - Chief Experience & Brand Officer, both effective mid-August 2026. Dr. N. Venkatesan resigned as Senior Director & Chief Procurement Officer, effective Aug 31, 2026. In-principle approval was also given to explore setting up medical colleges.
Read the summary - High impact
Max Healthcare Q1 FY27 Revenue at ₹2,982 Cr, Up 16% YoY; PAT at ₹357 Cr
Max Healthcare reported Q1 FY27 revenue of ₹2,982 Cr, up 16% YoY. Network Operating EBITDA was ₹704 Cr (up 15% YoY), and PAT was ₹357 Cr (up 3% YoY). The company completed the acquisition of Kalinga Hospital for ~₹298 Cr and acquired Yerawada Properties. Board approved ₹425 Cr capex for MSSH Vaishali.
Read the summary - High impact
Max Healthcare Q1 FY27 Revenue at ₹2,982 Cr, Up 16% YoY; PAT ₹357 Cr
Max Healthcare Institute Ltd. reported Q1 FY27 gross revenue of ₹2,982 Cr, up 16% YoY. Network Operating EBITDA rose 15% YoY to ₹704 Cr, with PAT at ₹357 Cr. The company completed the acquisition of Kalinga Hospital for ~₹298 Cr and acquired Yerawada Properties Private Limited. Capital expenditure of ₹425 Cr was approved for a new tower at MSSH Vaishali.
Read the summary - High impact
Max Healthcare Approves Q1FY27 Results, ₹425 Cr Capex for Vaishali Expansion, New Hires
Max Healthcare reported its Q1FY27 results. The company approved a ₹425 Crore capex for expanding its Vaishali hospital, adding ~250 beds by November 2029. Ajay Vij was appointed Director - Chief Supply Chain & Procurement Officer, and Pawan Kumar Marella as Senior Director - Chief Experience & Brand Officer, both effective mid-August 2026. Dr. N. Venkatesan resigned as Senior Director & Chief Procurement Officer, effective August 31, 2026.
Read the summary - Low impact
Max Healthcare to Participate in Motilal Oswal Investor Conference on Aug 18
Max Healthcare Institute Limited representatives will attend the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026, in Mumbai. The meetings will be held in a physical mode, including one-on-one and group sessions. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Max Healthcare Schedules Q1 FY27 Earnings Call for Aug 14, 2026
Max Healthcare will host an earnings call on August 14, 2026, at 11:00 AM IST to discuss Q1 FY27 results. The results will be declared on August 13, 2026. The call will include a management discussion and Q&A session.
Read the summary - Low impact
Max Healthcare subsidiary KHL litigation continues; NCLT allows rectification of defect.
Max Healthcare's subsidiary Kalinga Hospital Ltd. (KHL) is involved in litigation. The NCLT allowed the opposing party to rectify a procedural defect in an interlocutory petition. The matter is now listed for further consideration on August 19, 2026.
Read the summary - Medium impact
Max Healthcare's 25th AGM: Minutes Approved, Dividend Declared, and Office Shift to Haryana
Max Healthcare Institute Limited held its 25th AGM on July 30, 2026. The meeting approved financial statements for FY26, declared a ₹2 per share final dividend, and approved the re-appointment of director Anil Kumar Bhatnagar. A significant resolution was the approval to shift the registered office from Maharashtra to Haryana. Remuneration for non-executive directors was approved, and cost auditor fees ratified.
Read the summary - High impact
Max Healthcare Holds 25th AGM, Discusses Growth, Acquisitions, and Dividend
Max Healthcare's 25th AGM on July 30, 2026, focused on robust FY26 performance with revenue at ₹10,538 crore and PAT at ₹1,631 crore. The company plans to double its bed capacity in five years, having acquired Kalinga Hospital and expanded existing facilities. A final dividend of ₹2 per share was proposed. Management addressed growth strategies, debt levels, and expansion plans, including potential entry into Hyderabad and Kolkata.
Read the summary - Medium impact
Max Healthcare's 25th AGM: Shareholders Approve Financials, Dividend, and Office Shift
Max Healthcare's 25th AGM on July 30, 2026, saw shareholder approval for FY25-26 financials and a ₹2 per share final dividend. Key approvals included director re-appointments, shifting the registered office to Haryana, and auditor remuneration. The meeting was held via video conference.
Read the summary - Medium impact
Max Healthcare Holds 25th AGM on July 30, 2026; Approves Dividend
Max Healthcare Institute Limited held its 25th AGM on July 30, 2026. The company declared a final dividend of ₹2 per equity share. Key business transacted included adopting FY26 financial statements and approving the shifting of its registered office to Haryana. The company also shared expansion plans to nearly double bed capacity in five years.
Read the summary - Low impact
Max Healthcare Subsidiary KHL Litigation Hearing Adjourned to August 4
Max Healthcare's subsidiary, Kalinga Hospital Ltd., is involved in litigation with BRS Capital Two Pte. Limited. The National Company Law Tribunal, Cuttack Bench, heard the case on July 23, 2026, and has adjourned it to August 4, 2026, for further hearing. No financial impact or settlements are reported.
Read the summary - Low impact
Max Healthcare: Certificate confirms no share dematerialization requests in Q1 FY27
Max Healthcare Institute Limited received a certificate from its registrar confirming no share dematerialization requests during the quarter ended June 30, 2026. This information will be hosted on the company's website.
Read the summary - Low impact
Max Healthcare to Participate in Investor Conference by Kotak Securities on July 14
Max Healthcare Institute Limited will participate in a group meeting organized by Kotak Securities Limited on July 14, 2026, in Delhi. No unpublished price-sensitive information will be shared during the event. The schedule is subject to change.
Read the summary - Medium impact
Max Healthcare Subsidiary KHL Litigation Hearing Adjourned to July 23
Max Healthcare's subsidiary, Kalinga Hospital Ltd. (KHL), is involved in litigation. An interlocutory petition seeking to stay KHL's Postal Ballot Notice regarding borrowing limits was heard by the NCLT on July 7, 2026. The NCLT adjourned the matter to July 23, 2026, for further hearing.
Read the summary - Low impact
Max Healthcare Joins 'Saksham Niveshak' Campaign for KYC & Unclaimed Dividend Update
Max Healthcare is participating in the 'Saksham Niveshak' campaign (April 1-July 9, 2026) to encourage shareholders to update KYC and claim unclaimed dividends. Electronic dividend payments are mandatory from November 18, 2025, requiring KYC compliance and updated bank details. Shareholders should contact RTA MUFG Intime India for assistance.
Read the summary - Medium impact
Max Healthcare: BSE & NSE Grant No-Objection for Promoter Reclassification
Max Healthcare Institute Limited received no-objection letters from BSE and NSE on July 1, 2026, for the re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category. This follows an application made on May 24, 2026, under SEBI regulations.
Read the summary - Medium impact
Max Healthcare Acquires 50.22% Stake in Yerawada Properties, Subsidiary Status Achieved
Max Healthcare acquired 100% of Class A equity shares in Yerawada Properties Private Limited (YPPL), securing 50.22% economic interest and subsidiary status. This is a step towards establishing a 450-bed hospital in Pune. The transaction was confirmed on June 30, 2026.
Read the summary - Low impact
Max Healthcare fined ₹32.8 Lakhs by Income Tax Dept for journal entry transactions
Max Healthcare Institute Limited received a penalty of ₹32,81,528 from the Income Tax Department. The penalty is for transactions settled via journal entries, deemed by the IT Department as non-prescribed loan/deposit modes. The company is appealing the order, and there is no other financial or operational impact.
Read the summary - Medium impact
Max Healthcare Announces 25th AGM on July 30, 2026, Recommends Final Dividend
Max Healthcare will hold its 25th AGM on July 30, 2026, via VC/OAVM. The Board recommended a final dividend of ₹2 per share for FY26. The record date for the dividend is July 3, 2026. The AGM will be conducted through video conference.
Read the summary - Low impact
Max Healthcare: Trading Window Closed July 1 for Q1 FY27 Results
Max Healthcare's trading window will be closed from July 1, 2026, until 48 hours after the declaration of Q1 FY27 unaudited financial results. The board meeting date for approving results will be announced later.
Read the summary - Low impact
Max Healthcare fined ₹11.33 Lakh by Income Tax Dept for vendor/employee transactions
Max Healthcare Institute Limited has been penalized ₹11.33 Lakh by the Income Tax Department. The penalty is for transactions with employees and vendors classified as loans/deposits. The company is filing an appeal against the order, and there is no other significant financial or operational impact.
Read the summary - Low impact
Max Healthcare AGM on July 30, 2026; July 3 Record Date for Final Dividend
Max Healthcare Institute Limited will hold its 25th AGM on July 30, 2026, via video conference. The record date for the final dividend for FY2025-26 is set for July 3, 2026. The Board recommended a final dividend of ₹2.00 per equity share.
Read the summary - Medium impact
Max Healthcare: AGM on July 30, Record Date July 3 for Final Dividend
Max Healthcare will hold its AGM on July 30, 2026. The record date for the final dividend for FY25-26 is July 3, 2026. A final dividend of ₹2.00 per share was recommended. Communications regarding TDS on dividend were sent on June 19, 2026, with a submission deadline of July 10, 2026.
Read the summary - Low impact
Max Healthcare to Participate in IIFL Invest India Conference on June 23, 2026
Max Healthcare's Chairman and MD will attend IIFL's Invest India Conference in London on June 23, 2026. The event includes one-on-one and group meetings. No unpublished price-sensitive information will be disclosed.
Read the summary - High impact
Max Healthcare Q4 FY26: Revenue up 10% to ₹2,664 Cr, EBITDA ₹682 Cr
Max Healthcare reported Q4 FY26 revenue of ₹2,664 crore, a 10% YoY increase. Operating EBITDA was ₹682 crore, up 8% YoY. PAT stood at ₹387 crore. The company acquired Kalinga Hospital and approved a ₹1,400 crore investment for a new hospital in Lucknow. Brownfield capacity expansion is underway.
Read the summary - Low impact
Max Healthcare to Participate in Investor Conferences in June 2026
Max Healthcare Institute Limited will participate in investor conferences in June 2026. The company's management will attend Citi's 2026 India Conference in Mumbai on June 4, 2026, and Jefferies India Access Day 2026 in New York on June 8-9, 2026. No unpublished price-sensitive information will be disclosed.
Read the summary - Low impact
Max Healthcare to Present at UBS Asian Investment Conference 2026 in Hong Kong
Max Healthcare's Chairman and Managing Director will participate in the UBS Asian Investment Conference 2026 on May 27-28, 2026, in Hong Kong. An investor presentation will be made during the conference, and it will be available on the company's website.
Read the summary - Low impact
Max Healthcare Applies for Re-classification of Radiant Life Care Foundation
Max Healthcare Institute Limited applied to stock exchanges on May 24, 2026, for re-classifying Radiant Life Care Hospital Foundation from Promoter Group to Public category. This follows Board approval and is in line with SEBI regulations.
Read the summary - Low impact
Max Healthcare to Participate in UBS Asian Investment Conference 2026 in Hong Kong
Max Healthcare Institute Limited's Chairman and MD will attend the UBS Asian Investment Conference 2026 in Hong Kong on May 27-28, 2026. The event includes one-on-one and group meetings. No price-sensitive information will be disclosed.
Read the summary - Low impact
Max Healthcare Publishes Q4 FY26 Financial Results in Newspapers
Max Healthcare Institute Limited published its standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results were published on May 22, 2026, in Business Standard and Navshakti newspapers.
Read the summary - Low impact
Max Healthcare: Audio Recording of Q4 FY26 Earnings Call Available Online
Max Healthcare Institute Limited has made the audio recording of its earnings call held on May 22, 2026, available online. The call pertained to the financial results for the quarter and financial year ended March 31, 2026. The recording is accessible on the company's website.
Read the summary - Medium impact
Max Healthcare Wins CCI Case: No Abuse of Dominant Position Found
Max Healthcare's network hospitals have won a case against the Competition Commission of India (CCI). The CCI ruled on May 21, 2026, that there was no abuse of dominant position. This decision closes the investigation initiated earlier regarding pricing practices.
Read the summary - High impact
Max Healthcare Board Approves FY26 Results, Recommends Dividend, Approves Lucknow Hospital Expansion
Max Healthcare announced audited FY26 results and recommended a final dividend of ₹2 per share. The Board approved Phase-I construction of a new hospital in Lucknow (capacity ~712 beds) and approved the re-appointment of Mr. Anil Kumar Bhatnagar as Director for three years.
Read the summary - Medium impact
Max Healthcare Approves FY26 Financials, Recommends ₹2 Dividend, Expands Lucknow Hospital
Max Healthcare's Board approved FY26 audited financial results. A final dividend of ₹2 per share was recommended. The company approved the construction of Phase-I of its Lucknow hospital and the shifting of its registered office to Haryana. Mr. Anil Kumar Bhatnagar was re-appointed as a Director.
Read the summary - High impact
Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend, Approves Lucknow Hospital & Haryana Shift
Max Healthcare approved FY26 audited financial results. The Board recommended a final dividend of ₹2 per share. Construction of a new hospital in Lucknow and shifting the registered office to Haryana were approved. Radiant Life Care Hospital Foundation's re-classification was also sanctioned, pending regulatory approvals. Mr. Anil Kumar Bhatnagar was re-appointed as Director.
Read the summary - High impact
Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend, Approves Lucknow Hospital Project
Max Healthcare's Board approved FY26 audited financial results and recommended a ₹2 per share final dividend. The company also approved the construction of a new ~712-bed hospital in Lucknow and the shifting of its registered office to Haryana. The re-appointment of a Non-Executive Director was also approved.
Read the summary - High impact
Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend, Approves Lucknow Hospital Construction
Max Healthcare approved FY26 audited standalone and consolidated results ending March 31, 2026. The board recommended a final dividend of ₹2 per equity share. Approval was given for the construction of Phase-I of a new hospital in Lucknow and the shifting of the registered office to Haryana. Mr. Anil Kumar Bhatnagar was re-appointed as a Non-Executive Director.
Read the summary - High impact
Max Healthcare Q4 FY26 Revenue at ₹2,664 Cr (+10% YoY), PAT at ₹387 Cr
Max Healthcare's Q4 FY26 revenue rose 10% YoY to ₹2,664 Cr, with Operating EBITDA at ₹682 Cr (+8% YoY) and PAT at ₹387 Cr (+3% YoY). For FY26, revenue grew 16% to ₹10,538 Cr. The company completed the acquisition of Kalinga Hospital Ltd. and approved a ₹1,400 Cr greenfield hospital in Lucknow.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio